16 February 2023 - - US-based blood collection solutions provider Tasso, Inc's TassoOne Plus, a new high-volume liquid blood collection device, has received CE Mark certification and successfully fulfilled all of the performance, safety, and relevant product requirements under the new European Union Medical Device Regulation, the company said.

With this CE Mark, Tasso now expands its capabilities to offer patient-centric, high-volume blood collection solutions for the European market.

The TassoOne Plus is the latest addition to Tasso's signature line of CE Marked blood collection solutions for dried and liquid samples.

Users collect their own blood through an easy, virtually painless process that can be completed at home.

The process generates higher volumes and superior sample quality compared to traditional remote blood sampling techniques.

The clinical-grade samples fit seamlessly into existing downstream analysis workflows, empowering pharmaceutical companies, healthcare organizations, and academic institutions across the European Economic Area.

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach.

The company's devices enable simple, convenient, and virtually painless blood collection for users.

Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders.